Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0.763. It has been cited 161 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.763
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 3R01AI134907-03S2
A High-Throughput Platform for COVID-19 Serodiagnosis, Vaccine Evaluation, and Drug Discovery
National Institutes of Health
Grant: 5UL1TR001439-07
UTMB Clinical and Translational Science Award
National Institutes of Health
Grant: 5U19AI142759-04
Antiviral Drug Discovery and Development Center (AD3C)
National Institutes of Health
Grant: 1R43AI145617-01A1
Discovery and Development of Broad-spectrum Protease Inhibitors of Flaviviruses of Significant Public Health Threats
NIAID NIH HHS
Grant: R01 AI134907
NIAID NIH HHS
Grant: R43 AI145617
NIAID NIH HHS
Grant: U19 AI142759
NCATS NIH HHS
Grant: UL1 TR001439
Fields of Study
Keywords
Sustainable Development Goals